It is unclear if and how exogenous oxytocin (OT) reaches the brain to improve social
behavior and cognition and what is the optimal dose for OT response. To better understand …

Accumulating evidence suggests that intranasal oxytocin (OXT; 24 IU) reduces amygdala
responses to fear-related stimuli in men, while exerting inverse effects in women. However …

Background Current neuroimaging perspectives on a variety of mental disorders emphasize
dysfunction of the amygdala. The neuropeptide oxytocin (OXT), a key mediator in the …

BackgroundThe neuropeptide oxytocin is proposed as a promising therapy for social
dysfunction by modulating amygdala-mediated social-emotional behavior. Although clinical …

Intranasal oxytocin exerts wide-ranging effects on socioemotional behavior and is proposed
as a potential therapeutic intervention in psychiatric disorders. However, following intranasal …

Oxytocin (OXT) is a neuropeptide which has a critical role in human social behaviour and
cognition. Research investigating the role of OXT on functional brain changes in humans …

Abnormalities in responses to human facial emotions are associated with a range of
psychiatric disorders. Addressing these abnormalities may therefore have significant clinical …

A growing body of literature has suggested that intranasal oxytocin (OT) or other systemic
routes of administration can alter prosocial behavior, presumably by directly activating OT …

The hypothalamic peptide oxytocin (OT) is crucial in social adaptation and used to treat
emotional and social deficits. Here, we conducted a systematic, quantitative meta-analysis of …

Intranasal oxytocin is attracting attention as a potential treatment for several brain disorders
due to promising preclinical results. However, translating findings to humans has been …